Stocks

About Us

Home

Stocks

Dr. Reddy's Laboratories Ltd.

The current prices were last updated on 20 Jan.

Join waitlist

Dr. Reddy's Laboratories Ltd.

₹1,302.35

+171.97 (15.21%)

Sector:

Healthcare

Industry:

Pharmaceuticals & Drugs

Healthcare

Pharmaceuticals & Drugs

NSE

BSE

The current prices were last updated on 20 Jan

Price

0.97%

-2.46%

-4.38%

-3.81%

-1.04%

15.21%

42.76%

113.11%

Max

127.68%

-2.46%

-4.38%

15.21%

42.76%

113.11%

Max

127.68%

Overview

Financials

Ratios

Shareholdings

FAQs

Dr. Reddy's Lab Overview

1,293.65

Today's Low

1,309.00

Today's High

1,308.35

Open

1,309.40

Prev. Close

1,120.00

52W Low

1,421.49

52W High

P/E

18.41

Sector P/E

30.83

P/B

3.65

Sector P/B

3.10

Adj EPS

66.88

BVPS

1,686.06

OPM(%)

28.32

NPM(%)

19.91

ROE(%)

21.76

ROCE(%)

26.86

D/E

0.07

Div. Yld(%)

0.65

Dr. Reddy's Lab Historical Returns

1 Week

-2.46 %

1 Month

-4.38 %

3 Month

-3.81 %

6 Month

-1.04 %

1 Year

15.21 %

3 Year

42.76 %

5 Year

113.11 %

Max

127.68 %

Dr. Reddy's Lab Financials

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

*All values are in Rs. Cr

Consolidated

Name	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Net Sales	8,038.20	7,696.10	7,113.80	7,236.80
Sales	8,038.20	7,696.10	7,113.80	7,236.80
Less: Excise Duty	0	0	0	0
Operating Expenses	5,961.70	5,566.20	5,282.60	5,213.70
Raw Material Cost	1,287.20	1,227.20	1,096.20	1,141.20
Power cost	0	0	0	0
Employee Cost	1,399.20	1,413.70	1,283.60	1,276.40
Other Expenses	3,275.30	2,925.30	2,902.80	2,796.10
Increase / Decrease In Stocks	-203.30	-425.60	-180.00	-173.50
Purchase of Finished Goods	1,282.80	1,380.10	1,175.90	1,208.30
Manufacturing Expenses	2,103.40	1,970.30	1,924.20	0
General Administration Expenses	0	0	0	0
Selling & Distribution Expenses	0	0	0	1,750.30
Misc Expenses	92.40	0.50	-17.30	11.00
Loss Foreign Exchange	0	0	0	0
Loss Foreign Exchange Loan	0	0	0	0
Expenses Capitalised	0	0	0	0
Operating Profit (Excluding OI)	2,076.50	2,129.90	1,831.20	2,023.10
Other Income	307.50	187.20	197.50	216.20
Other Income Normal	307.50	187.20	197.50	216.20
Exceptional Items	0	0	0	0
Operating Profit Margin	25.83	27.68	25.74	27.96
EBIDTA	2,384.00	2,317.10	2,028.70	2,239.30
Less: Interest	75.70	59.80	59.30	39.40
Less: Depreciation	397.00	380.60	367.70	373.50
Profit Before Tax	1,917.40	1,882.60	1,605.20	1,829.10
Less: Tax	575.50	490.20	295.40	448.20
Net Profit	1,341.90	1,392.40	1,309.80	1,380.90
Earnings Per Share	15.08	83.61	78.66	82.94
Net Profit Margin	16.69	18.09	18.41	19.08

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Net Sales	28,011.10	24,669.70	21,545.20	19,047.50
Sales	28,011.10	24,669.70	21,545.20	19,047.50
Less: Excise Duty	-	-	-	-
Operating Expenses	20,078.00	18,320.70	17,777.80	15,177.60
Raw Material Cost	8,889.20	7,586.80	7,796.10	6,869.40
Power cost	533.90	477.40	390.50	320.50
Employee Cost	5,030.10	4,646.60	3,885.80	3,629.90
Other Expenses	6,305.30	5,539.00	6,059.30	5,148.30
Other Manufacturing Expenses	2,087.20	1,738.60	1,602.20	1,574.40
Selling and administrative expenses	1,968.80	1,497.50	1,547.60	1,251.80
Selling Expenses	2,127.50	1,989.40	1,919.20	1,567.70
Miscellaneous Expenses	121.80	313.50	990.30	754.40
Less: Expenses Capitalised	-	-	-	-
Operating Profit (Excluding OI)	7,933.10	6,349.00	3,767.40	3,869.90
Other Income	894.30	1,055.50	484.70	291.40
Other Income Normal	894.30	1,055.50	484.70	291.40
Exceptional Items	-	-	-	-
Operating Profit Margin	28.32	25.74	17.49	20.32
EBIDTA	8,827.40	7,404.50	4,252.10	4,161.30
Interest	171.10	142.80	95.80	97.00
Depreciation	1,470.00	1,250.20	1,165.20	1,228.80
Profit Before Tax	7,201.00	6,048.50	3,061.40	2,883.50
Tax	1,623.10	1,541.20	878.90	931.90
Net Profit	5,577.90	4,507.30	2,182.50	1,951.60
Equity Dividend %	800.00	800.00	600.00	500.00
Earnings Per Share	334.41	270.55	131.16	117.28
Net Profit Margin	19.91	18.27	10.13	10.25

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Equity And Liabilities	37,806.00	31,579.90	28,469.90	25,548.20
Shareholder's Funds	28,254.80	23,286.10	19,212.40	17,641.70
Share Capital	83.40	83.30	83.20	83.20
Share Warrants & Outstandings	131.30	145.70	143.30	126.60
Total Reserves	28,040.10	23,057.10	18,985.90	17,431.90
Reserve excluding Revaluation Reserve	28,040.10	23,057.10	18,985.90	17,431.90
Revaluation reserve	-	-	-	0
Non-Current Liabilities	-36.80	-278.30	-508.30	-197.30
Secured Loans	219.00	127.80	194.60	249.90
Unsecured Loans	380.00	-	380.00	380.00
Deferred Tax Assets / Liabilities	-973.70	-629.20	-1,275.60	-1,039.70
Other Long Term Liabilities	337.90	223.10	192.70	212.50
Rest of the Other Long Term Liabilities	314.00	203.20	166.90	161.70
Long Term Trade Payables	-	-	-	-
Long Term Provisions	23.90	19.90	25.80	50.80
Current Liabilities	9,588.00	8,572.10	9,765.80	8,103.80
Trade Payables	2,614.40	2,268.40	2,266.20	1,810.90
Other Current Liabilities	4,775.20	4,697.90	3,660.60	3,338.10
Short Term Borrowings	1,272.30	739.00	2,708.20	2,314.50
Short Term Provisions	926.10	866.80	1,130.80	640.30
Assets	37,806.00	31,579.90	28,469.90	25,548.20
Non-Current Assets	13,017.40	11,263.80	10,682.00	10,997.90
Net Block	10,425.60	9,219.10	8,121.50	8,205.70
Gross Block	28,062.20	25,567.10	23,096.40	21,886.70
Less: Accumulated Depreciation	17,636.10	16,348.00	14,894.90	13,632.10
Less: Impairment of Assets	0.50	-	80.00	48.90
Lease Adjustment	-	-	-	-
Capital Work in Progress	1,351.00	975.20	1,279.60	953.90
Other Non Current Assets	1,172.50	1,014.60	1,267.10	1,227.10
Long Term Investments	542.20	645.60	593.00	833.30
Long Term Loans & Advances	541.80	355.90	451.70	377.00
Other Non Current Assets	88.50	13.10	222.40	16.80
Current Assets	24,788.60	20,316.10	17,787.90	14,535.20
Inventories	6,355.20	4,867.00	5,088.40	4,541.20
Account Receivables	8,029.80	7,248.50	6,676.40	4,964.10
Cash and Bank	1,727.70	1,730.20	2,419.20	2,078.80
Other Current Assets	8,675.90	6,470.40	3,603.90	2,951.10
Current Investments	4,388.30	4,340.20	2,022.90	1,378.50
Other Current Assets	1,060.10	1,203.50	736.90	849.90
Short Term Loans and Advances	3,227.50	926.70	844.10	722.70
Book Value	1,686.06	1,388.98	1,145.98	1,052.59

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Cash from Operating Activity	4,543.30	5,887.50	2,810.80	3,570.30
Profit Before Tax	7,201.00	6,048.50	3,061.40	2,883.50
Adjustments	1,365.20	1,695.90	2,333.80	2,087.20
OCF Before Working Capital	8,566.20	7,744.40	5,395.20	4,970.70
Working Capital Changes	-2,018.20	-785.50	-1,840.70	-828.80
Taxes Paid	-2,004.70	-1,071.40	-743.70	-571.60
Cash from Investing Activity	-4,028.30	-4,137.30	-2,638.70	-2,266.00
Net Fixed Assets Purchased	-	-	-	-
Fixed Assets Purchased	-	-	-	-
Fixed Assets Sold	-	-	-	-
Investment Purchased	7,201.00	6,048.50	3,061.40	2,883.50
Investment Sold	-	-	-	-
Dividends Recieved	-	-	-	-
Interest Recieved	-	-	-	-
Subsidiary Investments	-	-	-	-
Cash from Financing Activity	-376.30	-2,686.10	-242.20	-29.80
Proceeds From Shares	-	-	-	-
Net Long Term Borrowings	-	-	-	-
Proceeds From Borrowings	-	-	-	-
Repayment From Borrowings	-	-	-	-
Interest Paid	-	-	-	-
Dividend Paid	-	-	-	-
Net Cash Flow	138.70	-935.90	-70.10	1,274.50
Opening Cash & Cash Equivalents	577.90	1,485.20	1,482.00	196.20
Effect of FX	-5.90	28.60	73.30	11.30
Closing Cash & Cash Equivalents	-	-	-	-
Free Cash Flow (est)	-	-	-	-
Net Capex (est)	-	-	-	-

*All values are in Rs. Cr

Dr. Reddy's Lab Financial Ratios

Valuations

Profitability

Efficiency

Leverage

Operational

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Book Value Per Share	1,686.06	1,388.98	1,145.98	1,052.59	932.31
P/B	3.65	3.33	3.76	4.29	3.34
P/E	18.41	17.08	32.83	38.50	25.57
EV/EBIDTA	11.66	10.35	17.08	18.29	17.41
Market Cap/Sales	3.67	3.12	3.33	3.94	2.96

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Net Profit Margin (%)	19.91	18.27	10.13	10.25	11.57
Gross Margin (%)	28.32	25.74	17.49	20.32	14.10
Operating Profit Margin (%)	28.32	25.74	17.49	20.32	14.10

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
ROE (%)	21.76	21.36	11.93	11.82	13.76
ROCE (%)	26.86	26.22	14.59	15.49	11.12
ROA (%)	16.08	15.01	8.08	8.21	9.20
Capital Adequacy Ratio (%)	-	-	-	-	-

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
D/E Ratio	0.07	0.06	0.18	0.17	0.14
Interest Coverage Ratio	43.09	43.36	32.96	30.73	20.18
Current Ratio	2.59	2.37	1.82	1.79	1.75

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash Conversion Cycle (Days)	64.10	68.59	80.19	72.70	70.42
Days Receivables (Days)	99.54	103.01	98.60	95.74	93.92
Inventory Days (Days)	73.12	73.65	81.57	77.11	71.52
Days Payables (Days)	108.56	108.07	99.98	100.14	95.02
Free Cash Flow to Share	137.06	185.20	-23.91	65.84	109.75
Inventory Turnover Ratio	4.99	4.96	4.47	4.73	5.10
Asset Turnover Ratio	0.81	0.82	0.80	0.80	0.80

Dr. Reddy's Lab Shareholding Pattern

Summary

Promoter

FII

MF

Retail

Others

Dr. Reddy's Lab Shareholding Breakup

Name	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Promoter	26.64%	26.65%	26.65%	26.65%
Indian Promoters	26.64	26.65	26.65	26.65
Foreign Promoters	-	-	-	-
FII	27.53%	27.68%	29.13%	28.62%
MF	10.86%	10.05%	7.96%	8.22%
Retail	8.07%	8.07%	8.25%	8.44%
Others	26.90%	27.55%	28.01%	28.07%

Dr. Reddy's Lab FAQs

What is the current share price of Dr. Reddy's Lab?

As of 20 Jan, the current share price of Dr. Reddy's Lab is ₹1302.35 per share.

What is the P/E ratio of Dr. Reddy's Lab?

The Price-to-Earnings (P/E) ratio of Dr. Reddy's Lab is 18.41. It is calculated based on its most recent quarterly earnings. The P/E ratio compares the company's current share price to its quarterly earnings per share (EPS), helping investors evaluate its market value relative to its earnings.

What is the EPS for Dr. Reddy's Lab?

As reported in the latest quarterly financial statements, the Earnings Per Share (EPS) for Dr. Reddy's Lab is ₹66.88. EPS is calculated by dividing the company's net income for the quarter by the number of outstanding shares, indicating how much profit is allocated to each share of stock during that period.

What is the ROE and ROCE of Dr. Reddy's Lab?

As per latest financial reports, Dr. Reddy's Lab has a Return on Equity (ROE) of 21.76% and a Return on Capital Employed (ROCE) of 26.86%. ROE measures the profitability relative to shareholders' equity, while ROCE assesses how efficiently the company utilizes its capital to generate profits.

What is the debt-to-equity ratio of Dr. Reddy's Lab?

The debt-to-equity ratio of Dr. Reddy's Lab is 0.07 according to its latest financial report. This ratio compares the company's total liabilities to its shareholder equity and is used to evaluate its financial leverage and risk level.

Similar stocks

SUNPHARMA

1778.25

NSE

+14.95

(0.85%)

DIVISLAB

6000.60

NSE

+84.55

(1.43%)

CIPLA

1445.45

NSE

+1.95

(0.14%)

MANKIND

2704.70

NSE

+159.45

(6.26%)

TORNTPHARM

3164.25

NSE

-14.35

(0.45%)

Excited to Invest?

Join our waitlist now and get early access to our platform!

Similar stocks

SUNPHARMA

1778.25

NSE

+14.95

(0.85%)

DIVISLAB

6000.60

NSE

+84.55

(1.43%)

CIPLA

1445.45

NSE

+1.95

(0.14%)

MANKIND

2704.70

NSE

+159.45

(6.26%)

TORNTPHARM

3164.25

NSE

-14.35

(0.45%)

Excited to Invest?

Join our waitlist now and get early access to our platform!

TRADE CONFIDENTLY

Address - 2nd Floor HSR Layout, 17th cross road Bengaluru – 560103

+91-8197368610

Home

About us

All stocks

Partners

NIFTY Top 10

Reliance Industries Limited

Tata Consultancy Services Limited

HDFC Bank Limited

Bharti Airtel Limited

ICICI Bank Limited

Infosys Limited

State Bank of India

Hindustan Unilever Limited

Life Insurance Corporation Of India

ITC Limited

Connect with us

Mintcap Brokers Private Limited

SEBI Registration : INZ000322732 | BSE Membership No: 6903

NSE Membership No : 90430